ibandronic acid has been researched along with EHS Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauss, F; Kim, SZ; Kurth, AA; Sedlmeyer, I; Shea, M | 1 |
1 other study(ies) available for ibandronic acid and EHS Tumor
| Article | Year |
|---|---|
Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Ibandronic Acid; Mammary Neoplasms, Experimental; Osteolysis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental | 2002 |